A minimum dataset for a standard adult transthoracic echocardiogram: a guideline protocol from the British Society of Echocardiography

Wharton, Gill; Steeds, Richard P.; Allen, Jim; Phillips, Hollie; Jones, Richard E.; Kanagala, Prathap; Lloyd, Guy; Masani, Navroz; Mathew, Thomas; Oxborough, David; Rana, Bushra S.; Sandoval, Julie; Wheeler, Richard; O’Gallagher, Kevin; Sharma, Vishal

doi:10.1530/erp-14-0079

Cited by 144 publications

(119 citation statements)

References 0 publications

Supporting

Mentioning

117

Contrasting

Unclassified

Order By: Relevance

“…A full standard echocardiogram was undertaken by a single experienced sonographer using a commercially available ultrasound system (Vivid Q, GE Healthcare, Horten, Norway) and a 1.5-4 MHz phased array transducer. All images were acquired in accordance with British Society of Echocardiography guidelines [16]. Images were stored in a raw DICOM format and exported to an offline workstation (EchoPac version 6.0, GE Healthcare, Horten, Norway) for subsequent analysis.…”

Section: Methodsmentioning

confidence: 99%

Left and right ventricular longitudinal strain-volume/area relationships in elite athletes

Oxborough

Heemels²,

Somauroo

et al. 2016

Int J Cardiovasc Imaging

Self Cite

View full text Add to dashboard Cite

groups IA and IIIA (50 ± 6 and 54 ± 8 ml/(m 2 ) 1.5 versus 42 ± 7 and 43 ± 2 ml/(m 2 ) 1.5 respectively). Group IIIC also had significantly larger mean wall thickness (MWT) compared to all groups. Athletes from group IIIC required greater longitudinal strain for any given % volume which correlated to MWT (r = 0.4, p < 0.0001). Findings were similar in the RV with the exception that group IIIC athletes required lower strain for any given % area. There are physiological differences between athletes with the largest LV and RV in athletes from group IIIC. These athletes also have greater resting longitudinal contribution to volume change in the LV which, in part, is related to an increased wall thickness. A lower longitudinal contribution to area change in the RV is also apparent in these athletes.

show abstract

Section: Methodsmentioning

confidence: 99%

Left and right ventricular longitudinal strain-volume/area relationships in elite athletes

Oxborough

Heemels²,

Somauroo

et al. 2016

Int J Cardiovasc Imaging

Self Cite

View full text Add to dashboard Cite

show abstract

“…For example, when a referral is made for an immediate echocardiogram querying massive pulmonary embolus, it may be neither appropriate nor possible to perform a full study; right heart strain or direct evidence of an embolus should instead be sought. In such patients, a complete study in compliance with the BSE minimum dataset (25) could be performed, if it is clinically indicated, in the fullness of time. When protocols become available for the management of specific aspects of critical illness – for example, when assessing fluid balance (26) – these criteria should be followed.…”

Section: Discussion: a Proposed Set Of Quality Indicators For A Satelmentioning

confidence: 99%

Measuring and monitoring quality in satellite echo services within critical care: an exploration of best practice

Thomas

Colebourn

2015

Echo Res Pract

View full text Add to dashboard Cite

The subspecialty of critical care echocardiography is a rapidly developing area of cardiac imaging. The United Kingdom Committee for Critical Care Echocardiography was set up in 2009 to examine the remit of echocardiography in critical care, and a successful collaboration between the British Society of Echocardiography (BSE) and the Intensive Care Society has resulted in the establishment of two new critical care accreditation processes: Focused Intensive Care Echocardiography and Advanced Critical Care Echocardiography. These accreditation processes are currently driving the development of satellite echo services within critical care departments throughout the UK. Individual practitioner – and more recently, departmental – accreditation have become well-established processes advocated by the BSE. Practitioner accreditation promotes accountability, and departmental accreditation standardises the environment in which practitioners operate. The accreditation of individual echocardiographers has been embraced by the critical care fraternity; we propose that departmental accreditation for critical care echo services be viewed in the same way. Identifying quality indicators for satellite echocardiography services within critical care areas is therefore the focus of the present quality exploration: our aim is to propose a set of parameters against which satellite critical care echo services can be benchmarked. In publishing our suggestions, we hope to stimulate debate in light of the rapid evolution of critical care echocardiography as a subspecialty practice. We suggest that our proposed parameters could be used to maintain satellite critical care service standards and to help identify departments capable of delivering high-quality services and training in critical care echocardiography.

show abstract

“…The detection of changes in structure and function in native valves may be subtle and echocardiography should be performed by properly‐trained, accredited professionals . In each case, a standard transthoracic study should be performed following minimum standards . In addition to this, however, careful attention should be taken to perform semi‐quantitative assessment of valve structure and function to detect the changes typical of DA agonist therapy.…”

Section: Recommendations On Surveillancementioning

confidence: 99%

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology

Steeds

Stiles

Sharma

et al. 2019

Clinical Endocrinology

Self Cite

View full text Add to dashboard Cite

Summary This is a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology on the role of echocardiography in monitoring patients receiving dopamine agonist (DA) therapy for hyperprolactinaemia. Evidence that DA pharmacotherapy causes abnormal valve morphology and dysfunction at doses used in the management of hyperprolactinaemia is extremely limited. Evidence of clinically significant valve pathology is absent, except for isolated case reports around which questions remain. Attributing change in degree of valvar regurgitation, especially in mild and moderate tricuspid regurgitation, to adverse effects of DA in hyperprolactinaemia should be avoided if there are no associated pathological changes in leaflet thickness, restriction or retraction. Note must be taken that even where morphological change in leaflet structure and function may be suspected, grading is semi‐quantitative on echocardiography and may vary between different machines, ultrasound settings and operators. Decisions regarding discontinuation of medication should only be made after review of serial imaging by an echocardiographer experienced in analysing drug‐induced valvulopathy or carcinoid heart disease. A standard transthoracic echocardiogram should be performed before a patient starts DA therapy for hyperprolactinaemia. Repeat transthoracic echocardiography should then be performed at 5 years after starting cabergoline in patients taking a total weekly dose less than or equal to 2 mg. If there has been no change on the 5‐year scan, repeat echocardiography could continue at 5‐yearly intervals. If a patient is taking more than a total weekly dose of 2 mg, then annual echocardiography is recommended.

show abstract

A minimum dataset for a standard adult transthoracic echocardiogram: a guideline protocol from the British Society of Echocardiography

Cited by 144 publications

References 0 publications

Left and right ventricular longitudinal strain-volume/area relationships in elite athletes

Left and right ventricular longitudinal strain-volume/area relationships in elite athletes

Measuring and monitoring quality in satellite echo services within critical care: an exploration of best practice

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology

Contact Info

Product

Resources

About